---
title: "Luye Pharma Completes Transfer of 25% Stake in Nanjing Luye to NJ Xinshi"
description: "Luye Pharma Group Ltd. has finalized the transfer of a 25% equity stake in its subsidiary, Nanjing Luye, to NJ Xinshi. As of January 19, 2026, Nanjing Luye is now 75% owned by Luye Pharma and 25% by N"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/273756696.md"
published_at: "2026-01-26T23:00:46.000Z"
---

# Luye Pharma Completes Transfer of 25% Stake in Nanjing Luye to NJ Xinshi

> Luye Pharma Group Ltd. has finalized the transfer of a 25% equity stake in its subsidiary, Nanjing Luye, to NJ Xinshi. As of January 19, 2026, Nanjing Luye is now 75% owned by Luye Pharma and 25% by NJ Xinshi. This partnership agreement ensures that Luye Pharma retains control over Nanjing Luye's governance and strategic objectives.

Luye Pharma Group Ltd. has completed the transfer of a 25% equity interest in its subsidiary, Nanjing Luye, to NJ Xinshi. Following the completion of the transaction on 19 January 2026, Nanjing Luye is now owned 75% by Luye Pharma Group and 25% by NJ Xinshi. The company stated that the partnership agreement and related transactions allow the Group to maintain control over the identity of Nanjing Luye’s partner, supporting continuity, governance stability, and alignment of strategic objectives. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260127-12001713), on January 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [603368.CN - GUANGXI LIUYAO GROUP](https://longbridge.com/en/quote/603368.CN.md)
- [02186.HK - LUYE PHARMA](https://longbridge.com/en/quote/02186.HK.md)
- [44018.HK - LUYE PHARMA POFF](https://longbridge.com/en/quote/44018.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Luye Pharma Subsidiary Issues Exchangeable Preference Shares to Bluebell Asset Holding | Luye Pharma Group Ltd.'s subsidiary, Luye Geneora Holding Limited, issued 1,500,000 exchangeable preference shares to Bl | [Link](https://longbridge.com/en/news/269536074.md) |
| Luye Pharma Appoints Xia Lian to Nomination Committee | Luye Pharma Group Ltd. has appointed Ms. Xia Lian, an independent non-executive director, to its Nomination Committee, e | [Link](https://longbridge.com/en/news/271205840.md) |
| Guofu Hydrogen Energy Equipment Wins Fusion Research Cold Box Project | Guofu Hydrogen Energy Equipment Wins Fusion Research Cold Box Project | [Link](https://longbridge.com/en/news/276677117.md) |
| Solar-powered truck charging gains ground on South Africa’s freight corridors | Solar-powered truck charging gains ground on South Africa’s freight corridors | [Link](https://longbridge.com/en/news/276976321.md) |
| Trump's Global Tariff Kicks In At 10% From Tuesday, Instead Of 15% | U.S. Customs and Border Protection has implemented a 10% tariff on all non-exempt goods effective from Tuesday, instead  | [Link](https://longbridge.com/en/news/276741600.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.